Fir Tree Capital Management’s AbbVie ABBV Stock Holding History

Fir Tree Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-535,788	Closed	-$57.8M	–	725
2021 Q3	$57.8M	Sell	535,788 -55,571	-9%	-$6.35M	1.95%	3
2021 Q2	$66.6M	Sell	591,359 -47,321	-7%	-$5.33M	2.5%	3
2021 Q1	$69.1M	Buy	638,680 +10,451	+2%	+$1.12M	2.76%	3
2020 Q4	$67.3M	Buy	+628,229	New	+$60.4M	3.27%	8

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fir Tree Capital Management's ABBV Position: Q4 2021 in Review

Fir Tree Capital Management sold out of AbbVie (ABBV) in Q4 2021, closing a stake of 535,788 shares — an estimated $57.8M sold.

Fir Tree Capital Management first reported a position in ABBV in Q4 2020 and held it in 4 quarters. The position peaked at $69.1M in Q1 2021. 2,982 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.

Fir Tree Capital Management reported no remaining AbbVie position as of Q4 2021 after selling out during the quarter.
Fir Tree Capital Management sold 535,788 AbbVie shares in Q4 2021, an estimated $57.8M.
Fir Tree Capital Management first reported a position in AbbVie in Q4 2020 and held it in 4 quarters.
Fir Tree Capital Management's AbbVie position peaked at $69.1M in Q1 2021.
2,982 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.

Based on Fir Tree Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.